Another drug: Tripathy's research and clinical
Post# of 155320
(Total Views: 454)
Posted On: 05/31/2025 10:58:23 AM
Another drug:
Tripathy's research and clinical trials contributed to the FDA approval of Ibrance, a CDK4/6 inhibitor, for the treatment of advanced breast cancer. Ibrance is a breakthrough drug that has changed the standard of care for advanced breast cancer patients.
___
Ibrance is owned by Pfizer
Dr. Tripathy is an outstanding, well rounded, perfect scientific fit for Leronlimab.
Great addition to Team Cytodyn !!
Tripathy's research and clinical trials contributed to the FDA approval of Ibrance, a CDK4/6 inhibitor, for the treatment of advanced breast cancer. Ibrance is a breakthrough drug that has changed the standard of care for advanced breast cancer patients.
___
Ibrance is owned by Pfizer
Dr. Tripathy is an outstanding, well rounded, perfect scientific fit for Leronlimab.
Great addition to Team Cytodyn !!
(8)
(0)